{"title":"Clinical characteristics and prognostic factors of ascitic fungal infections in patients with cirrhosis.","authors":"Xiaoxi Li, Xin Zhang, Fuyu Lu, Yuhao Yi, Suming Chen, Fusheng Wang, Chunmei Bao, Lei Huang","doi":"10.1016/j.dld.2026.10.024","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.024","url":null,"abstract":"<p><strong>Background and aims: </strong>To investigate the clinical characteristics, pathogen spectrum, antifungal susceptibility, and prognostic factors of ascitic fungal infections in patients with cirrhosis.</p><p><strong>Methods: </strong>This retrospective study included cirrhotic patients with positive ascitic fungal cultures. Patients with ascitic bacterial infections served as controls. Clinical, laboratory, and microbiological data were analyzed.</p><p><strong>Results: </strong>A total of 108 patients were included, comprising 57 with spontaneous fungal peritonitis (SFP) and 51 with fungiascites (FA). Among 116 fungal isolates recovered from ascitic fluid, 107 were Candida spp. Most isolates were susceptible to antifungal agents, although notable azole resistance was observed among non-albicans Candida species. Patients with SFP had higher mortality than those with FA (29.8% vs 13.7%, p = 0.045) and spontaneous bacterial peritonitis (29.8% vs 7.0%, p = 0.002). A nomogram incorporating serum urea (>18 mmol/L), neutrophil count (>10 × 10<sup>9</sup>/L), and platelet count (<75 × 10<sup>9</sup>/L) may facilitate early assessment of 30-day mortality.</p><p><strong>Conclusions: </strong>Ascitic fluid fungal infections, particularly SFP, are associated with significantly worse outcomes than bacterial ascitic infections. The primary pathogens are Candida spp., with high susceptibility to azole antifungals.</p>","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Children are not small adults: adult-derived evidence and reporting inconsistencies in pediatric endoscopy.","authors":"Jia Chen, Xu Zhang, Lei Zhu","doi":"10.1016/j.dld.2026.10.020","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.020","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Author's Reply: ``Follow-up eligibility and predictive value estimation in hepatocellular carcinoma risk stratification''.","authors":"Mohamed Moussa, Dave Sprengers, M J Sonneveld","doi":"10.1016/j.dld.2026.10.034","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.034","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beyond physician perspectives: advancing simultaneous care in pancreatic adenocarcinoma through multidisciplinary and implementation science approaches.","authors":"Jing Su, Juan Yang, Qiuqiong Li, Na Li","doi":"10.1016/j.dld.2026.10.029","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.029","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"When mucosa is quiet but symptoms persist: why EoE deserves more than an empiric dilatation.","authors":"Jianlei Zhang, Wenbin Dai, Pan Zhou","doi":"10.1016/j.dld.2026.09.006","DOIUrl":"https://doi.org/10.1016/j.dld.2026.09.006","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ilona Shapiro, Ebuwa Igho-Osagie, Sarah Sharman Moser, Garrett Lawlor, Moshe Hoshen, Gui Liu, Sivan Gazit, Florian Rieder, Amir Ben-Tov
{"title":"Fibrotic complications in ulcerative colitis are associated with early and persistent healthcare burden.","authors":"Ilona Shapiro, Ebuwa Igho-Osagie, Sarah Sharman Moser, Garrett Lawlor, Moshe Hoshen, Gui Liu, Sivan Gazit, Florian Rieder, Amir Ben-Tov","doi":"10.1016/j.dld.2026.10.031","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.031","url":null,"abstract":"<p><strong>Background and aims: </strong>Ulcerative colitis (UC) is traditionally considered a mucosal, non-fibrostenosing inflammatory bowel disease, yet emerging evidence suggests that fibrosis is more clinically relevant in UC than previously recognized. Population-based data describing the risk factors and healthcare burden of fibrotic complications in UC are limited.</p><p><strong>Methods: </strong>We conducted a retrospective population-based cohort study using data from Maccabi Healthcare Services, a nationwide insurer-provider. Non-malignant strictures, stenosis, or obstruction post-UC diagnosis were used as a proxy for fibrotic complications. Risk factors were assessed using Cox regression. Patients with fibrotic complications were then matched to controls to compare healthcare resource utilization (HCRU) and treatment patterns.</p><p><strong>Results: </strong>Among 6,944 patients with UC, 100 (1.4%) developed fibrotic complications. Older age at diagnosis (HR [95%CI]=1.81[1.05-3.13] for ages 41-65 and 2.75[1.30-5.80] for >65 vs. 18-40), comorbidities (1.73[1.04-2.88]), and advanced therapy exposure (4.38[2.47-7.74]) were independently associated with increased risk of fibrotic complications, whereas proctitis at presentation was protective (0.49[0.31-0.78]). Patients with fibrotic complications had higher HCRU, medication use, and costs throughout the disease course, evident even before fibrotic complication diagnosis, with a further increase in HCRU post-diagnosis.</p><p><strong>Conclusions: </strong>Fibrotic complications in UC are associated with substantial clinical and healthcare burden, underscoring the need for improved risk stratification, earlier recognition, and further investigation of targeted antifibrotic strategies.</p>","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Interpreting early bile acid reduction for pruritus reassessment in PFIC.","authors":"Xin Chang","doi":"10.1016/j.dld.2026.10.033","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.033","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Run-Zhi Wang, Cheng-Xian Ma, Huan-Wei Liang, Wei Huang, Xin-Bin Pan
{"title":"Neoadjuvant immunochemotherapy vs. neoadjuvant chemotherapy or concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma.","authors":"Run-Zhi Wang, Cheng-Xian Ma, Huan-Wei Liang, Wei Huang, Xin-Bin Pan","doi":"10.1016/j.dld.2026.10.032","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.032","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the efficacy between neoadjuvant immunochemotherapy (NICT), neoadjuvant chemotherapy (NCT), and concurrent chemoradiotherapy (CCRT) in patients with unresectable locally advanced esophageal squamous cell carcinoma.</p><p><strong>Materials and methods: </strong>We retrospectively analyzed patients with stage II-IVA disease treated between January 2013 and May 2024. Patients were categorized into the CCRT, NCT, and NICT groups. Survival outcomes were compared using Kaplan-Meier analysis and Cox proportional hazards models.</p><p><strong>Results: </strong>A total of 347 patients were included: 214 (61.7%) in the CCRT group, 42 (12.1%) in the NCT group, and 91 (26.2%) in the NICT group. Compared with CCRT, NICT was associated with improved disease-free survival (HR = 0.57, 95% CI: 0.41-0.80, P = 0.001) and overall survival (HR = 0.48, 95% CI: 0.32-0.72, P < 0.001). Compared with NCT, NICT was associated with improved disease-free survival (HR = 0.51, 95% CI: 0.32-0.79, P = 0.003) and overall survival (HR = 0.40, 95% CI: 0.24-0.65, P < 0.001). The survival benefit associated with NICT was observed in patients who received >3 cycles (HR = 0.31, 95% CI: 0.15-0.63, P = 0.001).</p><p><strong>Conclusion: </strong>NICT was associated with improved survival compared with either NCT or CCRT. These findings are hypothesis-generating and require prospective validation.</p>","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jessica Rondena, Roberta Gualtierotti, Roberto Carlo Rossi, Luca Valenti
{"title":"Awareness and clinical management of metabolic dysfunction-associated steatotic liver disease among physicians in Milan: a cross-sectional survey.","authors":"Jessica Rondena, Roberta Gualtierotti, Roberto Carlo Rossi, Luca Valenti","doi":"10.1016/j.dld.2026.10.023","DOIUrl":"https://doi.org/10.1016/j.dld.2026.10.023","url":null,"abstract":"","PeriodicalId":11268,"journal":{"name":"Digestive and Liver Disease","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149319034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}